Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin versus unfractionated heparin during primary PCI for ST-elevation acute coronary syndrome
ChiCTR-TRC-08000269Phase 4Completed
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Jan 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute coronary syndrome (ACS) and coronary arteriosclerosis comparing UFH group with Enoxaparin group (2 arms). Primary endpoints: Composite thrombotic and major bleeding/safety events, In-hospital mortality and 1 more. Started Jan 2008; status: completed.
02
Drugs
enoxaparinheparin
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-08000269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000269.